Evaluation of diabetes care at Austrian GPs - DCA09
Study identifier:NIS-CAT-DUM-2009/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Terminated/Withdrawn
Official Title
Diabetes Care Austria 2009
Medical condition
Type 2 Diabetes
Phase
-
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
1513
Study type
Observational
Age
N/A
Date
Study Start Date: 01 Oct 2009
Primary Completion Date: 01 Jan 2010
Study Completion Date: 01 Jan 2010
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Jan 2015 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
Bristol-Myers Squibb GesmbH
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| Patients with type 2 diabetes | - |
Contacts
Investigators
Principal Investigator
Bernhard Ludvig
General Hospital Vienna
